Ligand validation:6CQ9

R16: HEXADECANE

R16 is a Ligand Of Interest in 6CQ9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6CQ9_R16_A_405	47%	71%	0.117	0.9	0.3	0.82	-	-	0	0	75%	1
6CQ9_R16_B_410	45%	71%	0.108	0.895	0.3	0.82	-	-	0	0	69%	1
6CQ9_R16_A_408	40%	73%	0.095	0.894	0.3	0.73	-	-	0	0	50%	1
6CQ9_R16_B_405	37%	70%	0.154	0.898	0.3	0.83	-	-	0	0	75%	1
6CQ9_R16_B_406	28%	71%	0.149	0.844	0.3	0.82	-	-	0	0	75%	1
6CQ9_R16_A_407	23%	71%	0.158	0.836	0.31	0.81	-	-	0	0	69%	1
6CQ9_R16_B_408	21%	78%	0.164	0.897	0.32	0.56	-	-	0	0	31%	1
6CQ9_R16_B_407	19%	79%	0.153	0.872	0.32	0.54	-	-	0	0	31%	1
6CQ9_R16_B_411	6%	71%	0.226	0.723	0.32	0.77	-	-	0	0	63%	1
6CQ9_R16_B_409	1%	79%	0.417	0.725	0.32	0.54	-	-	0	0	31%	1
6W8A_R16_B_410	53%	70%	0.117	0.934	0.29	0.84	-	-	0	0	69%	1
6CQ8_R16_B_411	50%	71%	0.116	0.92	0.33	0.76	-	-	0	0	69%	1
6W7C_R16_A_405	45%	69%	0.184	0.914	0.29	0.9	-	-	0	0	100%	1
6W8F_R16_B_402	39%	73%	0.126	0.92	0.31	0.73	-	-	0	0	50%	1
6W8C_R16_A_405	36%	71%	0.136	0.827	0.37	0.72	-	-	0	0	100%	1
6GUX_R16_A_302	71%	97%	0.092	0.913	0.16	0.16	-	-	1	0	100%	1
6S6C_R16_A_302	63%	99%	0.088	0.88	0.11	0.13	-	-	2	0	100%	1
4Y9H_R16_A_309	61%	67%	0.114	0.901	0.54	0.73	-	-	0	0	100%	1
6ZO6_R16_B_1132	56%	100%	0.119	0.889	0.09	0.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.